Published papers
Sugimoto, Yoshikazu
41-60 items (total 102)
Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant Cancer cells.
- Author
- Saeed ME, Abdelgadir H, Sugimoto Y, Khalid HE, Efferth T
- Publication Title
- Magazine name J Ethnopharmacol Start Page 644 - End Page 658 (Publication Date）2015/11）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Regulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells
- Author
- Katayama K, Noguchi K, Sugimoto Y.
- Publication Title
- Magazine name New Journal of Science Publisher Hindawi Publishing Corporation Start Page 476974 (Publication Date）2015/05）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
- Author
- Saeed M, Kadioglu O, Khalid H, Sugimoto Y, Efferth T.
- Publication Title
- Magazine name J Nutr Biochem. Publisher Elsevier Volume 26(Issue 1) Start Page 44 - End Page 56 (Publication Date）2015/01）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
A novel yeast cell-based screening identifies flavone as a tankyrase inhibitor.
- Author
- Yashiroda Y, Okamoto R, Hatsugai K, Takemoto Y, Goshima N, Saito T, Hamamoto M, Sugimoto Y, Osada H, Seimiya H, Yoshida M*.
- Publication Title
- Magazine name Biochem Biophys Res Commun Start Page 569-573 (Publication Date）2010/03）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Breast cancer resistance protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
- Author
- Usuda J*, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.
- Publication Title
- Magazine name Lung Cancer Start Page 198-204 (Publication Date）2010/02）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma.
- Author
- Takeshita A, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R.
- Publication Title
- Magazine name British journal of haematology Start Page 34-43 (Publication Date）2009）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.
- Author
- Noguchi K., Kawahara H, Kaji A, Katayama K, Mitsuhashi J, Sugimoto Y.
- Publication Title
- Magazine name Cancer Science (Publication Date）2009）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Breast cancer resistance protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
- Author
- Usuda J, Tsunoda Y, Ichinose S, Ishizumi T, Ohtani K, Maehara S, Ono S, Tsutsui H, Ohira T, Okunaka T, Furukawa K, Sugimoto Y, Kato H, Ikeda N.
- Publication Title
- Magazine name Lung Cancer (Publication Date）2009）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
- Author
- Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, Tsuruo T, Seimiya H.
- Publication Title
- Magazine name Cancer Science (Publication Date）2009）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.
- Author
- Takeshita A, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R.
- Publication Title
- Magazine name Leukemia (Publication Date）2009）
- Authorship Category
- Single Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.
- Author
- Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N*.
- Publication Title
- Magazine name Cancer Sci Start Page 2060-2068 (Publication Date）2009/11）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Environmental contamination due to preparation of cyclophosphamide and exposure of pharmacists to it.
- Author
- Hama T*, Aoyama T, Shirai T, Higuchi S, Yokokawa T, Sugimoto Y.
- Publication Title
- Magazine name Jpn J Pharm Health Care Sci Start Page 693-700 (Publication Date）2009/09）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib.
- Author
- Noguchi K, Kawahara H, Kaji A, Katayama K, Mitsuhashi J, Sugimoto Y*.
- Publication Title
- Magazine name Cancer Science Start Page 1701-1707 (Publication Date）2009/09）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
- Author
- Mashima T, Sato S, Okabe S, Miyata S, Matsuura M, Sugimoto Y, Tsuruo T, Seimiya H*.
- Publication Title
- Magazine name Cancer Sci Start Page 1556-1562 (Publication Date）2009/08）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.
- Author
- Takeshita A*, Yamakage N, Shinjo K, Ono T, Hirano I, Nakamura S, Shigeno K, Tobita T, Maekawa M, Kiyoi H, Naoe T, Ohnishi K, Sugimoto Y, Ohno R.
- Publication Title
- Magazine name Leukemia Start Page 1329-136 (Publication Date）2009/07）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukemia and lymphoma.
- Author
- Takeshita A*, Shinjo K, Yamakage N, Ono T, Hirano I, Matsui H, Shigeno K, Nakamura S, Tobita T, Maekawa M, Ohnishi K, Sugimoto Y, Kiyoi H, Naoe T, Ohno R.
- Publication Title
- Magazine name Br J Haematol Start Page 34-43 (Publication Date）2009/06）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.
- Author
- Katayama K, Shibata K, Mitsuhashi J, Noguchi K, Sugimoto Y.
- Publication Title
- Magazine name Anticancer Reserch Volume 29(Issue 4) Start Page 1059-1065 (Publication Date）2009/04）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Identification of cytochrome P450s required for fumitoremorgin biosynthesis in Aspergillus fumigatus.
- Author
- Kato, N, Suzuki H, Takagi H, Asami Y, Kakeya H, Uramoto M, Usui T, Takahashi S, Sugimoto Y, Osada H*.
- Publication Title
- Magazine name Chembiochem Start Page 920-928 (Publication Date）2009/03）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Identification of cytochrome P450s required for fumitremorgin biosynthesis in Aspergillus fumigatus.
- Author
- Kato, N, Suzuki H, Takagi H, Asami Y, Kakeya H, Uramoto M, Usui T, Takahashi S, Sugimoto Y, Osada H.
- Publication Title
- Magazine name Chembiochem: a European journal of chemical biology Volume 10(Issue 5) Start Page 920-928 (Publication Date）2009/03）
- Authorship Category
- Single Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Pharmacological Interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.
- Author
- Katayama K, Shibata K, Mitsuhashi J, Noguchi K, Sugimoto Y*.
- Publication Title
- Magazine name Anticancer Research Start Page 1059-1065 (Publication Date）2009/01）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With